Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), boosting the price target to ...

Verona Pharma isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are ...

In a report released today, Thomas Shrader from BTIG maintained a Buy rating on Verona Pharma (VRNA – Research Report), with a price ...

LegalZoom.com Inc (NASDAQ:LZ) is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 ...

Western officials are investigating whether devices planted at shipping hubs in Europe may have been a test run by Russian operatives for placing them on planes bound for the U.S. By Michael ...

Tens of thousands of U.S. citizens live in the Israeli-occupied territory, on opposing sides of an entrenched conflict, where neither Palestinians nor Israelis have much enthusiasm for Kamala ...

Canara Robeco Conservative Hybrid Fund (IDCW-M) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid Fund-Dir (G) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 81,352.88 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue ...

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...

Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...